Minneapolis, MN4 Active Studies

Endometrial Cancer Clinical Trials in Minneapolis, MN

Find 4 actively recruiting endometrial cancer clinical trials in Minneapolis, MN. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,599
Enrolling

Recruiting Endometrial Cancer Studies in Minneapolis

RecruitingMinneapolis, MNNCT06952504

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is a type of cancer that starts in the tissues ...

1,123 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingMinneapolis, MNNCT05797831

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The ...

268 participants
Kartos Therapeutics, Inc.
View Study Details
RecruitingMinneapolis, MNNCT04486352

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune checkpoint therapy with atezolizumab in participant with recurren...

148 participants
Alliance Foundation Trials, LLC.
View Study Details
RecruitingMinneapolis, MNNCT05705505

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Lo...

60 participants
Traws Pharma, Inc.
View Study Details

About Endometrial Cancer Clinical Trials in Minneapolis

Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.

There are currently 4 endometrial cancer clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 1,599 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Kartos Therapeutics, Inc., Alliance Foundation Trials, LLC. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Endometrial Cancer Clinical Trials in Minneapolis — FAQ

Are there endometrial cancer clinical trials in Minneapolis?

Yes, there are 4 endometrial cancer clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What endometrial cancer treatments are being tested?

The 4 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for endometrial cancer.

Data updated March 2, 2026 from ClinicalTrials.gov